This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43878334
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel 2002年学术文章 2002年学术文章 articol științific vitenskapelig artikkel 2002年学术文章 scientific article published in January 2002 জানুয়ারি ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tieteellinen artikkeli bài báo khoa học bilimsel makale videnskabelig artikel wetenschappelijk artikel мақолаи илмӣ artikulong pang-agham научная статья 2002年學術文章 2002年學術文章 επιστημονικό άρθρο teaduslik artikkel vědecký článek wissenschaftlicher Artikel 2002年学术文章 naučni članak artigo científico 2002年学术文章 article scientific artikel ilmiah artículu científicu espublizáu en 2002 article científic artikull shkencor научна статия scienca artikolo სამეცნიერო სტატია 2002年学术文章 2002 nî lūn-bûn articolo scientifico наукова стаття, опублікована в січні 2002 2002年學術文章 2002年の論文 مقالة علمية نشرت في يناير 2002 artykuł naukowy scientific article published in January 2002 vitskapeleg artikkel artigo científico artigo científico scientific article published in January 2002 artículo científico publicado en 2002 научни чланак 2002年學術文章 tudományos cikk 2002년 논문 article scientifique 2002年學術文章 научни чланак vedecký článok מאמר מדעי บทความทางวิทยาศาสตร์
p:P577
wds:Q43878334-30D5292F-BFDD-4D1D-B00E-CC29A376DB85
wdt:P577
2002-01-01T00:00:00Z
p:P2860
wds:Q43878334-27915A82-D01C-4164-B3A0-326611F51EC5 wds:Q43878334-28649F95-EADB-4B06-98B9-3009BE6680C7 wds:Q43878334-3B0DB8DD-431F-46E2-907E-FCABE0D65E7A wds:Q43878334-3DC61604-419C-4EA8-99C7-87501E7464D9 wds:Q43878334-434F861E-0993-4E0E-A5C7-BB0FCC38BA6B wds:Q43878334-04EAB82C-8B48-45A8-9D15-859207DB4198 wds:Q43878334-1523B995-BA1D-4917-AA7B-1E6A3159FD76 wds:Q43878334-1AF79144-F79B-49B3-AE86-9302A0598B30 wds:Q43878334-1FC79817-6FA7-4AAB-8654-491EB5103CFD wds:Q43878334-216ED201-3050-40C1-B680-9157BD8CF33D wds:Q43878334-8A8188CD-561E-4AFE-87D4-E443CB7765E9 wds:Q43878334-9DBDE059-5B6C-4F62-B2E7-96102286C310 wds:Q43878334-A70563FF-1C4A-4D73-B958-B513322D71FC wds:Q43878334-CA2B474C-C50A-4CF0-9018-14D87BAD8CFE wds:Q43878334-CC73A692-E7C0-49B5-97A8-BA78C1B11899 wds:Q43878334-53078C25-BE4C-4BFF-999F-F1463BF202C7 wds:Q43878334-54C989FD-08D0-4AB9-9886-21A3DEC8F3EE wds:Q43878334-70DCA80A-4B4F-4D73-9DCE-2DC986F6C661 wds:Q43878334-749ABF8F-2683-4D7F-AE77-E5EDE0B6C5C2 wds:Q43878334-D46A7981-1C09-4BA9-B6AB-84C9F0B1EEE7 wds:Q43878334-E4D555D9-C8AD-4093-B1B6-F2F971461527 wds:Q43878334-E95C9AC2-2C9C-4FFC-A0A1-D1861044A1CB wds:Q43878334-FCF290C3-352B-4E72-A07E-0EF8228BA6E1
wdt:P2860
wd:Q41723159 wd:Q29619953 wd:Q73272087 wd:Q39248407 wd:Q40880957 wd:Q37600476 wd:Q52326401 wd:Q70511273 wd:Q55384068 wd:Q41622536 wd:Q54966041 wd:Q36216632 wd:Q67485952 wd:Q33329288 wd:Q41113760 wd:Q33207812 wd:Q73764983 wd:Q40998211 wd:Q74594861 wd:Q41456758 wd:Q34355593 wd:Q77323142 wd:Q36466856
p:P2093
wds:Q43878334-D3A2B4EF-A2EC-425F-808D-FC8B293D1495 wds:Q43878334-AC53A53C-49D4-4E4A-83DB-51D5F3B88C91 wds:Q43878334-82BA56A9-858F-4E8F-A949-68F230C0609F wds:Q43878334-01A7E394-A7D2-41C8-966C-E6DA9A129932
wdt:P2093
Hak Choy Hongryull Pyo Qianwen Cao George P Amorino
rdfs:label
Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells.
skos:prefLabel
Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells.
schema:name
Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells.
p:P50
wds:Q43878334-3F5FEA6E-FD9E-4644-9DD8-851FE8DB10F2
wdt:P50
wd:Q64355591
p:P1476
wds:Q43878334-78937F7E-262C-4446-814F-FDC033A12A21
wdt:P1476
Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells
p:P304
wds:Q43878334-23B55C52-250E-4C40-A54B-461BF64BFAD5
wdt:P304
61-67
p:P31
wds:Q43878334-D3D5130F-E764-4663-9C48-E9BC63A66296
wdt:P31
wd:Q13442814
p:P921
wds:Q43878334-F777104F-E470-4483-8A99-FA51443049A5
wdt:P921
wd:Q418817
p:P698
wds:Q43878334-59FB4F83-0D7F-4A22-B83D-B05368A06066
wdtn:P698
n10:11830313
wdt:P698
11830313
p:P1433
wds:Q43878334-1B38A6B9-7E72-4A0A-AADA-C6DE74FAE585
wdt:P1433
wd:Q14251029
p:P433
wds:Q43878334-B7AC5AFF-9E2E-4E2F-B321-3077EB4091FC
p:P478
wds:Q43878334-61D0B3DC-0758-4A4C-9D5E-49D657D6936C
wdt:P433
1
wdt:P478
62
p:P356
wds:Q43878334-256B48E3-B059-4C59-8950-B4C7B72ABD6B
wdtn:P356
n12:S0167-8140(01)00465-0
wdt:P356
10.1016/S0167-8140(01)00465-0